HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 160 filers reported holding HERON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.49 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $252,632 | -37.6% | 245,273 | -29.7% | 0.00% | – |
| Q2 2023 | $404,794 | -62.8% | 348,960 | -51.6% | 0.00% | -100.0% |
| Q1 2023 | $1,088,834 | -44.7% | 721,082 | -8.4% | 0.00% | -50.0% |
| Q4 2022 | $1,967,700 | -48.2% | 787,080 | -12.5% | 0.00% | -60.0% |
| Q3 2022 | $3,797,000 | -15.7% | 899,571 | -44.3% | 0.01% | 0.0% |
| Q2 2022 | $4,506,000 | -61.3% | 1,614,982 | -20.6% | 0.01% | -54.5% |
| Q1 2022 | $11,636,000 | -5.6% | 2,034,229 | +50.6% | 0.01% | +10.0% |
| Q4 2021 | $12,330,000 | -19.4% | 1,350,491 | -5.7% | 0.01% | -28.6% |
| Q3 2021 | $15,307,000 | -49.8% | 1,431,929 | -27.1% | 0.01% | -46.2% |
| Q2 2021 | $30,483,000 | -14.8% | 1,964,150 | -11.0% | 0.03% | -25.7% |
| Q1 2021 | $35,781,000 | -25.2% | 2,207,390 | -2.4% | 0.04% | -18.6% |
| Q4 2020 | $47,860,000 | +54.3% | 2,261,278 | +8.1% | 0.04% | +34.4% |
| Q3 2020 | $31,013,000 | -0.5% | 2,092,666 | -1.2% | 0.03% | -13.5% |
| Q2 2020 | $31,162,000 | +14.2% | 2,118,442 | -8.9% | 0.04% | -14.0% |
| Q1 2020 | $27,297,000 | -59.2% | 2,325,103 | -18.3% | 0.04% | -43.4% |
| Q4 2019 | $66,859,000 | +120.7% | 2,845,049 | +73.8% | 0.08% | +105.4% |
| Q3 2019 | $30,290,000 | +18.7% | 1,637,299 | +19.3% | 0.04% | +15.6% |
| Q2 2019 | $25,511,000 | -29.1% | 1,372,291 | -6.7% | 0.03% | -30.4% |
| Q1 2019 | $35,966,000 | +31.5% | 1,471,596 | +39.6% | 0.05% | +21.1% |
| Q4 2018 | $27,341,000 | +48.7% | 1,054,008 | +81.4% | 0.04% | +72.7% |
| Q3 2018 | $18,385,000 | +8.0% | 580,881 | +32.6% | 0.02% | 0.0% |
| Q2 2018 | $17,025,000 | -36.8% | 438,233 | -55.1% | 0.02% | -40.5% |
| Q1 2018 | $26,938,000 | +200.3% | 976,013 | +96.9% | 0.04% | +208.3% |
| Q4 2017 | $8,971,000 | +131.3% | 495,632 | +106.4% | 0.01% | +100.0% |
| Q3 2017 | $3,879,000 | +388.5% | 240,175 | +319.2% | 0.01% | +500.0% |
| Q2 2017 | $794,000 | +80.9% | 57,300 | +95.9% | 0.00% | 0.0% |
| Q1 2017 | $439,000 | +137.3% | 29,252 | +107.2% | 0.00% | – |
| Q4 2016 | $185,000 | -82.3% | 14,120 | -75.6% | 0.00% | -100.0% |
| Q2 2016 | $1,044,000 | +10.7% | 57,850 | +16.5% | 0.00% | 0.0% |
| Q1 2016 | $943,000 | -35.9% | 49,670 | -17.6% | 0.00% | 0.0% |
| Q3 2015 | $1,471,000 | -79.4% | 60,281 | -73.7% | 0.00% | -81.8% |
| Q2 2015 | $7,134,000 | +3756.2% | 228,938 | +1698.0% | 0.01% | – |
| Q1 2015 | $185,000 | -6.1% | 12,733 | -35.1% | 0.00% | – |
| Q4 2014 | $197,000 | – | 19,610 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |